Clinical evidence of hypersensitivity to low doses in radiotherapy

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study.

Leukemia·2017

Second primary malignancies in multiple myeloma: an overview and IMWG consensus.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.

Leukemia·2015

Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.

Journal of thrombosis and haemostasis : JTH·2014

Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.

Blood cancer journal·2014

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG).

Leukemia·2013

Risk and prognostic survival analysis of radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma: intensity-modulated radiotherapy and two-dimensional radiotherapy.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Patient-clinician symptom agreement before and after radiotherapy for prostate cancer: results from the randomized HYPO-RT-PC study.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

OPEN: optimising patient experience in head and neck radiotherapy, a phase 3 randomised control trial comparing open versus closed face masks.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Bayesian personalized dose constraints in selecting patients with non-small cell lung cancer for cardiac risk-adaptive treatment.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Testosterone monitoring and supplementation in patients with intermediate- or high-risk prostate cancer treated with 6-36 months of androgen deprivation therapy and radiotherapy: a systematic literature review.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Quality of life and pain-response after stereotactic ablative radiotherapy of oligometastatic bone metastases in the phase 2 BONY-M trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Coherently Enhanced Radiation Friction in Laser-Plasma Collisions.

Physical review letters·2026

Evidence of ZZγ Production and Observation of 4ℓγ in Proton-Proton Collisions at sqrt[s]=13 TeV.

Physical review letters·2026

Measurements of the Absolute Branching Fraction of the Semileptonic Decay Ξ^{-}→Λe^{-}ν[over ¯]_{e} and the Axial Charge of Ξ^{-}.

Physical review letters·2026

Related Experiment Videos

Clinical evidence of hypersensitivity to low doses in radiotherapy

Related Concept Videos

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study.

Second primary malignancies in multiple myeloma: an overview and IMWG consensus.

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.

Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.

Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG).

Risk and prognostic survival analysis of radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma: intensity-modulated radiotherapy and two-dimensional radiotherapy.

Patient-clinician symptom agreement before and after radiotherapy for prostate cancer: results from the randomized HYPO-RT-PC study.

OPEN: optimising patient experience in head and neck radiotherapy, a phase 3 randomised control trial comparing open versus closed face masks.

Bayesian personalized dose constraints in selecting patients with non-small cell lung cancer for cardiac risk-adaptive treatment.

Testosterone monitoring and supplementation in patients with intermediate- or high-risk prostate cancer treated with 6-36 months of androgen deprivation therapy and radiotherapy: a systematic literature review.

Quality of life and pain-response after stereotactic ablative radiotherapy of oligometastatic bone metastases in the phase 2 BONY-M trial.

Coherently Enhanced Radiation Friction in Laser-Plasma Collisions.

Evidence of ZZγ Production and Observation of 4ℓγ in Proton-Proton Collisions at sqrt[s]=13 TeV.

Measurements of the Absolute Branching Fraction of the Semileptonic Decay Ξ^{-}→Λe^{-}ν[over ¯]_{e} and the Axial Charge of Ξ^{-}.

Polarization Measurement of Λ_{c}^{+} and Λ[over ¯]_{c}^{-} Baryons in p-Ne Collisions at sqrt[s_{NN}]=68.6 GeV.

Evidence of ZZγ Production with the ATLAS Detector.

A setup for femtosecond two-photon absorption laser-induced fluorescence in fusion-relevant hydrogen plasmas.

Related Experiment Videos

Clinical evidence of hypersensitivity to low doses in radiotherapy

Related Concept Videos

Related Articles